The state of cost-benefit and cost-effectiveness analyses in education

被引:43
作者
Hummel-Rossi, B
Ashdown, J
机构
[1] NYU, Steinhardt Sch Educ, Dept Appl Educ, New York, NY 10003 USA
[2] NYU, Steinhardt Sch Educ, Dept Teaching & Learning, New York, NY 10003 USA
关键词
accountability; cost-benefit; cost-effectiveness; economic evaluation;
D O I
10.3102/00346543072001001
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
National and local pressures to improve student achievement, to implement educational reforms, to increase services. to "at risk" students, and to monitor the size of education budgets. all function as motivators for educators to consider the use of cost analysis in decisions about resource allocation. Yet the application Of cost-benefit and cost-effectiveness analyses in education is limited. The authors explore the advances in cost-benefit and cost-effectiveness analyses that have been made in the human services, health, and medical fields, and they identify the difficulties and analyze the issues involved in applying these analyses in education: They make recommendations for assessing costs and measuring effectiveness in educational evaluations, discuss the strengths and weaknesses of several exemplar cost-benefit and cost-effectiveness educational studies, and,provide a protocol to guide future analyses.
引用
收藏
页码:1 / 30
页数:30
相关论文
共 50 条
  • [41] Incorporating adherence in cost-effectiveness analyses of asthma: a systematic review
    Chongmelaxme, Bunchai
    Chaiyakunapruk, Nathorn
    Dilokthornsakul, Piyameth
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (06) : 554 - 566
  • [42] Cost-effectiveness analyses in neuropsychiatry and mental health
    Catala-Lopez, Ferran
    Ridao, Manuel
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2017, 45 (03): : 130 - 133
  • [43] Cost-utility and cost-benefit analyses of school-based obesity prevention program
    Xu, Haiquan
    Li, Yanping
    Du, Songming
    Zhang, Qian
    Liu, Ailing
    Sun, Junmao
    Ma, Guansheng
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [44] Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness
    Yuen, MF
    Lai, CL
    ANNALS OF ONCOLOGY, 2003, 14 (10) : 1463 - 1467
  • [45] Assesing the costs, benefits, cost-benefit ratio, and cost-effectiveness of martial and family treatments: Why we should and how we can
    Fals-Stewart, W
    Yates, BT
    Klosterman, K
    JOURNAL OF FAMILY PSYCHOLOGY, 2005, 19 (01) : 28 - 39
  • [46] Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review
    Grochtdreis, Thomas
    Koenig, Hans-Helmut
    Dobruschkin, Alexander
    von Amsberg, Gunhild
    Dams, Judith
    PLOS ONE, 2018, 13 (12):
  • [47] Cost-benefit analysis of stroke rehabilitation in Iran
    Darvishi, Ali
    Mousavi, Mirtaher
    Dezfouli, Ramin Abdi
    Shirazikhah, Marzieh
    Zarei, Mehdi Alizadeh
    Hendi, Hamidreza
    Joghataei, Faezeh
    Daroudi, Rajabali
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (06) : 659 - 669
  • [48] Cost-benefit analysis of a PMTCT program in Mozambique
    Peffer, D
    Osman, NB
    Vaz, P
    EVALUATION AND PROGRAM PLANNING, 2002, 25 (04) : 433 - 445
  • [49] Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
    Sanders, Gillian D.
    Neumann, Peter J.
    Basu, Anirban
    Brock, Dan W.
    Feeny, David
    Krahn, Murray
    Kuntz, Karen M.
    Meltzer, David O.
    Owens, Douglas K.
    Prosser, Lisa A.
    Salomon, Joshua A.
    Sculpher, Mark J.
    Trikalinos, Thomas A.
    Russell, Louise B.
    Siegel, Joanna E.
    Ganiats, Theodore G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (10): : 1093 - 1103
  • [50] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Y. Wan
    F. Zeng
    H. Tan
    Y. Lu
    Y. Zhang
    L. Zhao
    R. You
    Osteoporosis International, 2022, 33 : 979 - 1015